Komori
Sekisui Chemical (4204) · RiskMitigated

Sluggish orders for new homes due to a decline in visitors to showrooms

First written in FY2021-Q3. 2 of 3 entries say "Mitigated", first in FY2022-Q1. Latest entry: FY2022-Q2.

3entries
1years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021-Q3MitigatedFY2022-Q1 – FY2022-Q22021: 32021
Same theme, other companies
住宅展示場の来場減少による新築住宅受注低迷A theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Moved together

"Expanding domestic and overseas sales of diagnostic reagents and testing equipment" moved the same way as this thread, in the same document, in 2 of its 3 moves.

222222★123456
  1. ★This thread
  2. 1Expanding domestic and overseas sales of diagnostic reagents and testing equipment2×
  3. 2Accelerating growth in life sciences through the creation of the Medical segment2×
  4. 3Declining sales due to production adjustments for mobile devices2×
  5. 4Expanded adoption of molded plastic sheets in the construction, medical and railway sectors2×
  6. 5Decline in orders for the medical business2×
  7. 6Lower sales and profit due to shifts in the completion timing of new-build homes2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Sekisui Chemical's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.